These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3500279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
    Sheridan W, Gordon DS, Fullen AJ, Olson A, Vogler WR, Winton E.
    Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

  • 9. Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
    Aye MT, Dunne JV.
    Blood; 1981 Nov; 58(5):1043-6. PubMed ID: 6975136
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N, Russell N, Ganeshaguru K, Jackson BF, Piga A, Prentice HG, Foa R, Hoffbrand AV.
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [Abstract] [Full Text] [Related]

  • 12. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H, Kim J, Asofsky R, Thorbecke GJ, Hirschhorn R.
    J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
    [Abstract] [Full Text] [Related]

  • 13. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
    Kuroki Y, Shimoyama M, Inaba S, Hirose M.
    Jpn J Cancer Res; 1989 May; 80(5):482-9. PubMed ID: 2502523
    [Abstract] [Full Text] [Related]

  • 18. Decreased NAD+ content in human T lymphoblastoid cells treated simultaneously with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Koya M, Kanoh T, Uchino H, Ueda K.
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1003-11. PubMed ID: 3877388
    [No Abstract] [Full Text] [Related]

  • 19. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
    Hayward AR.
    Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
    [Abstract] [Full Text] [Related]

  • 20. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS, Kredich NM, Koller CA, Mitchell BS, Kurtzberg J, Kinney TR, Falletta JM.
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.